Delivery Order SPE2DR25D9101-SPE2DR26FKTA5
Award Date 10/30/25
Potential Completion Date 11/21/25
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a single delivery order without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. on September 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine formulation used for surgical site infiltration and nerve block anesthesia. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, will be delivered to Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a $25.1K delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 11, 2025, under a firm fixed-price arrangement. The work will be performed in Park Ridge, Illinois, where DMS...
- The Defense Logistics Agency awarded a $15,063.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine local anesthetic used for infiltration and nerve block procedures in surgical settings. The delivery order, which carries an ultimate completion date of July 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This award, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a routine pharmaceutical supply order without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected...
- This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain to DMS Pharmaceutical Group Inc., covers the supply of EXPAREL 266 mg/20 mL vials with a firm fixed price ceiling of $25,106.30 and an ultimate completion date of August 13, 2025. EXPAREL is a liposomal bupivacaine formulation used for surgical anesthesia and post-operative pain management. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a $3,014.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 22, 2025, for the supply of EXPAREL (liposomal bupivacaine) 133 mg/10 ml vials. EXPAREL is a long-acting local anesthetic commonly used in surgical and medical settings for pain management. The delivery order, which carries no set-aside designation, is scheduled for completion by October 14, 2025, with performance taking place at the vendor's facility in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials on September 23, 2025. This firm fixed-price delivery order is due for completion by October 15, 2025, with performance taking place at the vendor's location in Park Ridge, Illinois. The contract utilizes no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical supply market....
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $15,063.78 with an ultimate completion date of October 9, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply...